{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:20:33Z","timestamp":1790320833203,"version":"4.1.0"},"reference-count":16,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2016.5235","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T12:08:28Z","timestamp":1478606908000},"page":"77-82","source":"Crossref","is-referenced-by-count":53,"title":["EpCAM-independent capture of circulating tumor cells with a \u2018universal CTC-chip\u2019"],"prefix":"10.3892","volume":"37","author":[{"given":"Yasuhiro","family":"Chikaishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohnaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"key20180107224850_b1-or-37-01-0077","first-page":"108","article-title":"CTC enumeration and characterization: Moving toward personalized medicine","volume":"2","author":"Toss","year":"2014","journal-title":"Ann Transl Med"},{"key":"key20180107224850_b2-or-37-01-0077","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107224850_b3-or-37-01-0077","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107224850_b4-or-37-01-0077","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107224850_b5-or-37-01-0077","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer","volume":"14","author":"de Bono","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107224850_b6-or-37-01-0077","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-09-1095","article-title":"Circulating tumor cell as a diagnostic marker in primary lung cancer","volume":"15","author":"Tanaka","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107224850_b7-or-37-01-0077","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ncponc0839","article-title":"Malignant pleural mesothelioma: Current concepts in treatment","volume":"4","author":"Tsiouris","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"key20180107224850_b8-or-37-01-0077","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1245\/s10434-013-3399-2","article-title":"Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM)","volume":"21","author":"Yoneda","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key20180107224850_b9-or-37-01-0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201303698","article-title":"Biology, detection, and clinical implications of circulating tumor cells","volume":"7","author":"Joosse","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key20180107224850_b10-or-37-01-0077","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"key":"key20180107224850_b11-or-37-01-0077","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","article-title":"Detection of mutations in EGFR in circulating lung-cancer cells","volume":"359","author":"Maheswaran","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107224850_b12-or-37-01-0077","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10544-013-9775-7","article-title":"Polymeric microfluidic devices exhibiting sufficient capture of cancer cell line for isolation of circulating tumor cells","volume":"15","author":"Ohnaga","year":"2013","journal-title":"Biomed Microdevices"},{"key":"key20180107224850_b13-or-37-01-0077","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180107224850_b14-or-37-01-0077","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107224850_b15-or-37-01-0077","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","article-title":"Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium","volume":"23","author":"Sato","year":"2010","journal-title":"Mod Pathol"},{"key":"key20180107224850_b16-or-37-01-0077","first-page":"107","article-title":"Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients","volume":"2","author":"Ilie","year":"2014","journal-title":"What is the best blood substrate for personalized medicine? Ann Transl Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.5235\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T20:16:46Z","timestamp":1657657006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.5235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,8]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2016.5235"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.5235","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}